WO2002008760A8 - Method of identifying cancer markers and uses therefor in the diagnosis of cancer - Google Patents

Method of identifying cancer markers and uses therefor in the diagnosis of cancer

Info

Publication number
WO2002008760A8
WO2002008760A8 PCT/AU2001/000877 AU0100877W WO0208760A8 WO 2002008760 A8 WO2002008760 A8 WO 2002008760A8 AU 0100877 W AU0100877 W AU 0100877W WO 0208760 A8 WO0208760 A8 WO 0208760A8
Authority
WO
WIPO (PCT)
Prior art keywords
cancer
diagnosis
identifying
uses therefor
markers
Prior art date
Application number
PCT/AU2001/000877
Other languages
French (fr)
Other versions
WO2002008760A1 (en
Inventor
Christopher Richard Parish
Vivian Mae Cabalda-Crane
Original Assignee
Biotron Ltd
Christopher Richard Parish
Cabalda Crane Vivian Mae
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotron Ltd, Christopher Richard Parish, Cabalda Crane Vivian Mae filed Critical Biotron Ltd
Priority to EP01951237A priority Critical patent/EP1319178A4/en
Priority to NZ524197A priority patent/NZ524197A/en
Priority to AU2001272220A priority patent/AU2001272220A1/en
Priority to CA002416375A priority patent/CA2416375A1/en
Priority to KR10-2003-7000848A priority patent/KR20030031126A/en
Priority to JP2002514403A priority patent/JP2004504621A/en
Priority to BR0112644-0A priority patent/BR0112644A/en
Priority to US10/333,348 priority patent/US20040029194A1/en
Publication of WO2002008760A1 publication Critical patent/WO2002008760A1/en
Publication of WO2002008760A8 publication Critical patent/WO2002008760A8/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/08—Sphingolipids
    • G01N2405/10—Glycosphingolipids, e.g. cerebrosides, gangliosides

Abstract

The present invention provides a mass spectrometry-based method of identifying a cancer marker in sera and uses of said cancer marker in diagnosing cancer in human and non-human subjects. The invention further provides isolated cancer markers.
PCT/AU2001/000877 2000-07-19 2001-07-19 Method of identifying cancer markers and uses therefor in the diagnosis of cancer WO2002008760A1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
EP01951237A EP1319178A4 (en) 2000-07-19 2001-07-19 Method of identifying cancer markers and uses therefor in the diagnosis of cancer
NZ524197A NZ524197A (en) 2000-07-19 2001-07-19 Method for the diagnosis of cancer using matrix assisted laser desorption/ionisation time of flight mass spectrometry (MALDI-TOF MS) or electrospray MS
AU2001272220A AU2001272220A1 (en) 2000-07-19 2001-07-19 Method of identifying cancer markers and uses therefor in the diagnosis of cancer
CA002416375A CA2416375A1 (en) 2000-07-19 2001-07-19 Method of identifying cancer markers and uses therefor in the diagnosis of cancer
KR10-2003-7000848A KR20030031126A (en) 2000-07-19 2001-07-19 Method of Identifying Cancer Markers and Uses Therefor in the Diagnosis of Cancer
JP2002514403A JP2004504621A (en) 2000-07-19 2001-07-19 Methods for identifying marker traits of cancer in cancer diagnosis and uses for diagnosis
BR0112644-0A BR0112644A (en) 2000-07-19 2001-07-19 Method of identifying cancer markers and their uses in cancer diagnosis
US10/333,348 US20040029194A1 (en) 2000-07-19 2001-07-19 Method of identifying cancer markers and uses therefor in the diagnosis of cancer

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ8861A AUPQ886100A0 (en) 2000-07-19 2000-07-19 Diagnostic test
AUPQ8861 2000-07-19

Publications (2)

Publication Number Publication Date
WO2002008760A1 WO2002008760A1 (en) 2002-01-31
WO2002008760A8 true WO2002008760A8 (en) 2002-04-18

Family

ID=3822924

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2001/000877 WO2002008760A1 (en) 2000-07-19 2001-07-19 Method of identifying cancer markers and uses therefor in the diagnosis of cancer

Country Status (11)

Country Link
US (1) US20040029194A1 (en)
EP (1) EP1319178A4 (en)
JP (1) JP2004504621A (en)
KR (1) KR20030031126A (en)
CN (1) CN1449496A (en)
AU (1) AUPQ886100A0 (en)
BR (1) BR0112644A (en)
CA (1) CA2416375A1 (en)
NZ (1) NZ524197A (en)
WO (1) WO2002008760A1 (en)
ZA (1) ZA200301211B (en)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2457437A1 (en) * 2001-08-03 2003-02-20 Biotron Limited A novel cancer marker and uses therefor in the diagnosis of cancer
US20050170352A1 (en) * 2002-03-06 2005-08-04 Johns Hopkins University Use of biomarkers to detect breast cancer
US7402397B2 (en) 2002-05-21 2008-07-22 Monogram Biosciences, Inc. Detecting and profiling molecular complexes
US20040229294A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB surface receptor complexes as biomarkers
US20040229380A1 (en) * 2002-05-21 2004-11-18 Po-Ying Chan-Hui ErbB heterodimers as biomarkers
AU2002950878A0 (en) * 2002-08-20 2002-09-12 Proteome Systems Intellectual Property Pty Ltd Method for diagnosing disorders
DE10304106A1 (en) * 2003-01-31 2004-08-26 Mosaiques Diagnostics And Therapeutics Ag Method and device for the qualitative and / or quantitative determination of a protein and / or peptide pattern of a liquid sample which is taken from the human or animal body
US7425700B2 (en) * 2003-05-22 2008-09-16 Stults John T Systems and methods for discovery and analysis of markers
US20040236603A1 (en) * 2003-05-22 2004-11-25 Biospect, Inc. System of analyzing complex mixtures of biological and other fluids to identify biological state information
US7402399B2 (en) * 2003-10-14 2008-07-22 Monogram Biosciences, Inc. Receptor tyrosine kinase signaling pathway analysis for diagnosis and therapy
US7707039B2 (en) * 2004-02-15 2010-04-27 Exbiblio B.V. Automatic modification of web pages
EP2221618A3 (en) * 2004-04-20 2010-09-01 Board Of Regents Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disase in hematologic malignancies
US20050244973A1 (en) * 2004-04-29 2005-11-03 Predicant Biosciences, Inc. Biological patterns for diagnosis and treatment of cancer
US7651847B2 (en) * 2004-06-22 2010-01-26 The Regents Of The University Of California Methods of oligosaccharide profiling for the detection of cancer
JP2008539412A (en) 2005-04-26 2008-11-13 レイモンド， エー． ドウェック， Glycosylation markers for cancer diagnosis and monitoring
US8039208B2 (en) 2005-04-26 2011-10-18 National Institute For Bioprocessing Research And Training Limited (Nibrt) Automated strategy for identifying physiological glycosylation markers(s)
US7892752B2 (en) 2005-04-26 2011-02-22 Dwek Raymond A Glycosylation markers for cancer diagnosing and monitoring
US7491504B2 (en) * 2005-11-22 2009-02-17 Frantz Biomarkers, Llc Method for detecting ovarian cancer
US20080020472A1 (en) * 2005-11-22 2008-01-24 Frantz Biomarkers, Llc Method for detecting an inflammatory disease or cancer
US7482161B2 (en) * 2006-07-17 2009-01-27 Bio-Rad Laboratories, Inc. Preparation of a red blood cell component for a hematology control
JP5212893B2 (en) * 2008-05-09 2013-06-19 住友ベークライト株式会社 Diagnosis method of pancreatic cancer using N-linked sugar chain
SG186201A1 (en) * 2010-10-29 2013-01-30 Atonarp Inc Sampling apparatus
WO2012081508A1 (en) * 2010-12-13 2012-06-21 日本ケミカルリサーチ株式会社 Method for assaying glycosphingolipid
KR101384693B1 (en) * 2011-05-09 2014-04-14 국립암센터 Method of providing information for histologic type of non-small cell lung cancer using lipid profile
KR101314097B1 (en) 2011-05-11 2013-10-04 국립암센터 MALDI MS-based prediction method of the tissue origin of adenocarcinomas of unknown primary
KR101648926B1 (en) * 2015-09-03 2016-08-18 주식회사 아스타 Method for analyzing n-glycans in complex biological fluids
CN106950379B (en) * 2017-03-02 2019-01-22 江苏先思达生物科技有限公司 A kind of lung cancer monitoring reagent box and its application method
CN109655449B (en) * 2018-12-19 2021-10-01 杭州邦沃森生物科技有限公司 Method for measuring microcystin in fish meat by laser desorption
AU2020326698A1 (en) 2019-08-05 2022-02-24 Seer, Inc. Systems and methods for sample preparation, data generation, and protein corona analysis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5679636A (en) * 1992-03-30 1997-10-21 Board Of Regents, The University Of Texas Bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
WO1998000711A1 (en) * 1996-07-03 1998-01-08 Millenium Pharmaceuticals, Inc. Detection of cancer by assaying for cancer-specific antigens having linked oligosaccharides which are at least triantennary
CA2386669A1 (en) * 1999-10-07 2001-04-12 Ciphergen Biosystems, Inc. Prostate cancer marker proteins
US6936424B1 (en) * 1999-11-16 2005-08-30 Matritech, Inc. Materials and methods for detection and treatment of breast cancer

Also Published As

Publication number Publication date
ZA200301211B (en) 2004-02-04
WO2002008760A1 (en) 2002-01-31
EP1319178A1 (en) 2003-06-18
BR0112644A (en) 2003-06-24
US20040029194A1 (en) 2004-02-12
KR20030031126A (en) 2003-04-18
CN1449496A (en) 2003-10-15
JP2004504621A (en) 2004-02-12
NZ524197A (en) 2004-09-24
CA2416375A1 (en) 2002-01-31
EP1319178A4 (en) 2004-05-06
AUPQ886100A0 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
WO2002008760A8 (en) Method of identifying cancer markers and uses therefor in the diagnosis of cancer
CA2397772A1 (en) Method for determining the response to cancer therapy
SG83143A1 (en) Visual blood gluocose test strip
EP1314395A3 (en) Method for multi-site skin testing
AU2002309803A1 (en) Breath test for assessing diseases, particularly asthma
AU3367799A (en) Methodology for predicting and/or diagnosing disease
AU2001213151A1 (en) X-ray measuring and testing system
AU2002340169A8 (en) Identifying anti-tumor targets or agents by lipid raft immunization and proteomics
AU2002312411A1 (en) Microcalorimetric detection of analytes and binding events
HK1051895A1 (en) Test strip measuring method and device.
HK1027597A1 (en) Methods for identifying pathogenic markers in a sample of normal cells.
AU2002324881A1 (en) Diagnostic and prognostic tests
WO2001025791A3 (en) Prostate cancer marker proteins
IL135076A0 (en) An immunoassay diagnostic probe and a method for use thereof
EP1426838A3 (en) Timepiece
AU2002237662A1 (en) Analysis of soluble factor biological markers
WO2002023200A3 (en) Human breast cancer biomarkers
AU2001280732A1 (en) Pregnancy and sex identification test based on saliva or other bodily fluids
AU2002319445A1 (en) Diagnostic markers for determination of the life stage of a non-human animal and classification system based thereon
HUP0003843A2 (en) Strip test for diagnosing allergies in-vitro
EP1404861A4 (en) Methods and kits for diagnosing a pancreatic-based fat malabsorption disorder
AU6012798A (en) Genetic methods for identifying individuals for improving well being and perf ormance through exercise
WO2003056031A3 (en) Method and kit for detecting alkaline sphingomyelinase
WO2003040093A3 (en) Isotopically coded affinity marker 2
AU2001273675A1 (en) Methods and assays for diagnosing alzheimer's disease

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WR Later publication of a revised version of an international search report
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 2416375

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1020037000848

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2001951237

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2003/01211

Country of ref document: ZA

Ref document number: 200301211

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 524197

Country of ref document: NZ

Ref document number: 2001272220

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 018149375

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020037000848

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001951237

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10333348

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 524197

Country of ref document: NZ

WWG Wipo information: grant in national office

Ref document number: 524197

Country of ref document: NZ

WWW Wipo information: withdrawn in national office

Ref document number: 2001951237

Country of ref document: EP